These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 2062033)

  • 41. [Proteinuria in diabetes mellitus].
    Bratusch-Marrain P
    Acta Med Austriaca; 1988; 15(1):12-4. PubMed ID: 3287821
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Clinical and histological correlation of diabetic nephropathy.
    Afroz T; Sagar R; Reddy S; Gandhe S; Rajaram KG
    Saudi J Kidney Dis Transpl; 2017; 28(4):836-841. PubMed ID: 28748886
    [TBL] [Abstract][Full Text] [Related]  

  • 43. [Tubulointerstitial injury in diabetes mellitus (including Armanni-Ebstein lesion)].
    Watanabe Y; Hotta N
    Ryoikibetsu Shokogun Shirizu; 1997; (17 Pt 2):225-8. PubMed ID: 9277902
    [No Abstract]   [Full Text] [Related]  

  • 44. The patterns of proteinuria in diabetes mellitus. Relevance to pathogenesis and prevention of diabetic nephropathy.
    Viberti G; Keen H
    Diabetes; 1984 Jul; 33(7):686-92. PubMed ID: 6376224
    [No Abstract]   [Full Text] [Related]  

  • 45. Navigating pathways affecting type 1 diabetic kidney disease.
    Pasquali L; Trucco M; Ringquist S
    Pediatr Diabetes; 2007 Oct; 8(5):307-22. PubMed ID: 17850474
    [No Abstract]   [Full Text] [Related]  

  • 46. Pathogenesis of diabetic nephropathy.
    van Dijk C; Berl T
    Rev Endocr Metab Disord; 2004 Aug; 5(3):237-48. PubMed ID: 15211095
    [No Abstract]   [Full Text] [Related]  

  • 47. [Natural history of nephropathy in type I diabetes mellitus].
    Esmatjes E; Gutiérrez A; Goday A; Novials A; Ricart MJ; González MT; García M; Ríos M; Figuerola D
    Med Clin (Barc); 1988 Jan; 90(2):47-9. PubMed ID: 3347113
    [No Abstract]   [Full Text] [Related]  

  • 48. Chymase is upregulated in diabetic nephropathy: implications for an alternative pathway of angiotensin II-mediated diabetic renal and vascular disease.
    Huang XR; Chen WY; Truong LD; Lan HY
    J Am Soc Nephrol; 2003 Jul; 14(7):1738-47. PubMed ID: 12819233
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Activation of tubular epithelial cells in diabetic nephropathy.
    Morcos M; Sayed AA; Bierhaus A; Yard B; Waldherr R; Merz W; Kloeting I; Schleicher E; Mentz S; Abd el Baki RF; Tritschler H; Kasper M; Schwenger V; Hamann A; Dugi KA; Schmidt AM; Stern D; Ziegler R; Haering HU; Andrassy M; van der Woude F; Nawroth PP
    Diabetes; 2002 Dec; 51(12):3532-44. PubMed ID: 12453911
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Tubular epithelial cell activation and interstitial fibrosis. The role of glomerular ultrafiltration of growth factors in the nephrotic syndrome and diabetic nephropathy.
    Wang SN; Hirschberg R
    Nephrol Dial Transplant; 1999 Sep; 14(9):2072-4. PubMed ID: 10489207
    [No Abstract]   [Full Text] [Related]  

  • 51. Expression of transforming growth factor-beta1 and type IV collagen in the renal tubulointerstitium in experimental diabetes: effects of ACE inhibition.
    Gilbert RE; Cox A; Wu LL; Allen TJ; Hulthen UL; Jerums G; Cooper ME
    Diabetes; 1998 Mar; 47(3):414-22. PubMed ID: 9519748
    [TBL] [Abstract][Full Text] [Related]  

  • 52. [Recent advances concerning the pathogenesis of diabetic nephropathy].
    Scarpioni L
    Minerva Urol Nefrol; 1985; 37(1):5-8. PubMed ID: 3901336
    [No Abstract]   [Full Text] [Related]  

  • 53. High fructose diet feeding accelerates diabetic nephropathy in Spontaneously Diabetic Torii (SDT) rats.
    Toyoda K; Suzuki Y; Muta K; Masuyama T; Kakimoto K; Kobayashi A; Shoda T; Sugai S
    J Toxicol Sci; 2018; 43(1):45-58. PubMed ID: 29415951
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Etiologic variability of nephropathy in juvenile diabetes mellitus.
    Gilboa N; Durante D; McIntosh RM; Guggenheim S
    Arch Pathol Lab Med; 1979 Aug; 103(9):479-82. PubMed ID: 582380
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Inhibition of both neutral endopeptidase and endothelin-converting enzyme by SLV306 reduces proteinuria and urinary albumin excretion in diabetic rats.
    Thöne-Reinke C; Simon K; Richter CM; Godes M; Neumayer HH; Thormählen D; Hocher B
    J Cardiovasc Pharmacol; 2004 Nov; 44 Suppl 1():S76-9. PubMed ID: 15838365
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Non diabetic renal disease in type 2 diabetes mellitus.
    Soni SS; Gowrishankar S; Kishan AG; Raman A
    Nephrology (Carlton); 2006 Dec; 11(6):533-7. PubMed ID: 17199793
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Hemodynamic alteration in diabetic nephropathy measured by renal Doppler ultrasonography: does it predict the outcome of the disease?
    Tokgoz H; Turksoy O
    Clin Hemorheol Microcirc; 2005; 33(4):397-8. PubMed ID: 16317249
    [No Abstract]   [Full Text] [Related]  

  • 58. Association between oxidant/antioxidant markers and proteinuria in type 2 diabetes: results in 142 patients.
    Rashidi A; Nakhjavani M; Esteghamati A; Asgarani F; Khalilzadeh O; Abbasi M; Safari R
    J Nephrol; 2009; 22(6):733-8. PubMed ID: 19967652
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Osmotic polyuria: an overlooked mechanism in diabetic nephropathy.
    Wang S; Mitu GM; Hirschberg R
    Nephrol Dial Transplant; 2008 Jul; 23(7):2167-72. PubMed ID: 18456680
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Renal affection in patients with diabetes mellitus is not always caused by diabetic nephropathy.
    Zukowska-Szczechowska E; Tomaszewski M
    Rocz Akad Med Bialymst; 2004; 49():185-9. PubMed ID: 15631340
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.